Riskpilot← Back to searchSign inGet full accessAPO-NOR AS
ASActiveOrg 995466015Hundestedveien 8, 8003 BodøBusiness and other management consultancy activities · NACE 7020Est. 20102 employees
Revenue 2024
NOK 60K
-40% vs 2023
EBITDA margin
-3526.4%
-33% vs 2023
Equity ratio
79.1%
Financial strength
Net profit 2024
NOK 1,3M
-61% vs 2023
| Revenue | NOK 60K | -40% |
| EBITDA | NOK -2,1M | -33% |
| Net profit | NOK 1,3M | -61% |
| Total assets | NOK 43,9M | +3% |
| Equity | NOK 34,7M | +4% |
| Employees | 2 | — |
Legal name
APO-NOR AS
Org number
995466015
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
28. mai 2010
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Investering i aksjer, eierskap i apotek og det som naturlig hører hertil (aktuelle konsulent og rådgivertjenester i eget og underliggende selskaper).
Address
Hundestedveien 8, 8003 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 22 | 130 | 100 | 60 |
| Staff expenses | −1 032 | −1 085 | −1 262 | −1 323 | −1 323 |
| EBITDA | −1 700 | −1 736 | −10 944 | −1 591 | −2 116 |
| Depreciation & amort. | −9 | −9 | −9 | −9 | −9 |
| EBIT | −1 709 | −1 745 | −10 953 | −1 600 | −2 125 |
| Net financials | 1 928 | 492 | 576 | 4 965 | 3 454 |
| Profit before tax | 219 | −1 253 | −10 376 | 3 365 | 1 329 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 219 | −1 253 | −10 376 | 3 365 | 1 329 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 42 537 | 51 633 | 42 667 | 42 758 | 43 933 |
| Equity | 41 683 | 40 430 | 30 054 | 33 419 | 34 748 |
| Long-term debt | 0 | 0 | 4 875 | 4 621 | 0 |
| Short-term debt | 854 | 11 203 | 7 738 | 4 718 | 9 185 |
| Total debt | 854 | 11 203 | 12 613 | 9 339 | 9 185 |
EBITDA margin
-3526.4%
This company
15.8%
Market median
-22419% vs market
20202024
Equity ratio
79.1%
This company
38.2%
Market median
+107% vs market
20202024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20202024
Net profit margin
2214.9%
This company
8.1%
Market median
+27244% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 56% | 56% | 2022 | |
| Company | 16% | 16% | 2022 | |
| Company | 16% | 16% | 2022 | |
| Company | 12% | 12% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pmg Holding As
APO-NOR AS Board members of APO-NOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Magnus Vaag Guttelvik | Chief Executive Officer | 0 companies |
| Lars Holter Ingebrigtsen | Board of Directors | 0 companies |
| Sigrunn Astrid Vaag | Chairman | 0 companies |